Multiple Sclerosis

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hammack, B N
Right arrow Articles by Gilden, D H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hammack, B N
Right arrow Articles by Gilden, D H
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Multiple Sclerosis, Vol. 10, No. 3, 245-260 (2004)
DOI: 10.1191/1352458504ms1023oa

Proteomic analysis of multiple sclerosis cerebrospinal fluid

B N Hammack

Department of Neurology, University of Colorado Health Sciences Center, Denver, CO 80262, USA, barbara.hammack{at}ushsc.edu

K YC Fung

Biochemical Mass Spectrometry Facility, University of Colorado Health Sciences Center, Denver, CO 80262, USA

S W Hunsucker

Biochemical Mass Spectrometry Facility, University of Colorado Health Sciences Center, Denver, CO 80262, USA

M W Duncan

Biochemical Mass Spectrometry Facility, University of Colorado Health Sciences Center, Denver, CO 80262, USA

M P Burgoon

Department of Neurology, University of Colorado Health Sciences Center, Denver, CO 80262, USA

G P Owens

Department of Neurology, University of Colorado Health Sciences Center, Denver, CO 80262, USA

D H Gilden

Department of Neurology, University of Colorado Health Sciences Center, Denver, CO 80262, USA, Department of Microbiology, University of Colorado Health Sciences Center, Denver, CO 80262, USA

Two-dimensional gel electrophoresis and peptide mass fingerprinting were used to identify proteins in cerebrospinal fluid (C SF) pooled from three patients with multiple sclerosis (MS) and in C SF pooled from three patients with non-MS inflammatory central nervous system (C NS) disorders. Resolution of C SF proteins on three pH gradients (3-10, 4-7 and 6-11) enabled identification of a total of 430 spots in the MS C SF proteome that represented 61 distinct proteins. The gels containing MS C SF revealed 103 protein spots that were not seen on control gels. A ll but four of these 103 spots were proteins known to be present in normal human C SF. The four exceptio ns were: C RTAC -1B (cartilage acidic protein), tetranectin (a plasminogen-binding protein), SPARC -like protein (a calcium binding cell signalling glycoprotein), and autotaxin t (a phosphodiesterase). It remains unknown whether these four proteins are related to the cause and patho genesis of MS.

Key Words: cerebrospinal fluid • multiple sclerosis • proteomics


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mult SclerHome page
V. Lehmensiek, S. Sussmuth, G. Tauscher, J. Brettschneider, S. Felk, F. Gillardon, and H. Tumani
Cerebrospinal fluid proteome profile in multiple sclerosis
Multiple Sclerosis, August 1, 2007; 13(7): 840 - 849.
[Abstract] [PDF]


Home page
Arch NeurolHome page
Y. Kinoshita, T. Uo, S. Jayadev, G. A. Garden, T. P. Conrads, T. D. Veenstra, and R. S. Morrison
Potential Applications and Limitations of Proteomics in the Study of Neurological Disease
Arch Neurol, December 1, 2006; 63(12): 1692 - 1696.
[Full Text] [PDF]


Home page
Brief Funct Genomic ProteomicHome page
R. G. Biringer, H. Amato, M. G. Harrington, A. N. Fonteh, J. N. Riggins, and A. F. R. Huhmer
Enhanced sequence coverage of proteins in human cerebrospinal fluid using multiple enzymatic digestion and linear ion trap LC-MS/MS
Brief Funct Genomic Proteomic, June 1, 2006; 5(2): 144 - 153.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
A. Vanderver, R. Schiffmann, M. Timmons, K. A. Kellersberger, D. Fabris, E. P. Hoffman, J. Maletkovic, and Y. Hathout
Decreased Asialotransferrin in Cerebrospinal Fluid of Patients with Childhood-Onset Ataxia and Central Nervous System Hypomyelination/Vanishing White Matter Disease
Clin. Chem., November 1, 2005; 51(11): 2031 - 2042.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
T. D. Veenstra, T. P. Conrads, B. L. Hood, A. M. Avellino, R. G. Ellenbogen, and R. S. Morrison
Biomarkers: Mining the Biofluid Proteome
Mol. Cell. Proteomics, April 1, 2005; 4(4): 409 - 418.
[Abstract] [Full Text] [PDF]